1-Naphthyl 3,5-dinitrobenzoate

CAS No. 93261-39-3

1-Naphthyl 3,5-dinitrobenzoate( JMC-4 )

Catalog No. M27473 CAS No. 93261-39-3

1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
5MG 49 In Stock
10MG 79 In Stock
25MG 164 In Stock
50MG 254 In Stock
100MG 358 In Stock
200MG 489 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Naphthyl 3,5-dinitrobenzoate
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.
  • Description
    1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JMC-4
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    nAChR1|nAChR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93261-39-3
  • Formula Weight
    338.27
  • Molecular Formula
    C17H10N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC1=CC=CC=2C=CC=CC12)C=3C=C(C=C(C3)N(=O)=O)N(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jean-No?l Houchat, et al. Mode of Action of Sulfoxaflor on α-bungarotoxin-insensitive nAChR1 and nAChR2 Subtypes: Inhibitory Effect of Imidacloprid. Neurotoxicology. 2019 Sep;74:132-138.
molnova catalog
related products
  • 11-Keto-beta-boswell...

    11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor.

  • Utreloxastat

    Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis .

  • CJ-13,610 hydrochlor...

    CJ-13,610 hydrochloride is an orally active nonredox-type inhibitor of 5-LOX and can be used in studies about the prevention of untoward pathophysiological effects of LTs.